Tyler Menichiello
Tyler Menichiello is chief editor of Bioprocess Online, where he interviews biopharma executives and subject matter experts about the industry’s most pressing challenges. He aims to deliver actionable insights for biologics developers and manufacturers. Previously, he spent two years as a clinical research associate at the University of Pittsburgh Medical Center’s (UPMC) Hillman Cancer Center, working on clinical trials for hematological malignancies. He studied biology and journalism at Indiana University of Pennsylvania (IUP). You can connect with Tyler on LinkedIn.
ARTICLES BY TYLER MENICHIELLO
-
![Bio-live-Shaw]( "On The Ground At BPI: Takeda's Amy Shaw On Scaling Cell Therapy Manufacturing")
On The Ground At BPI: Takeda's Amy Shaw On Scaling Cell Therapy Manufacturing9/26/2025Takeda head of process development, Amy Shaw, explains what factors to consider when scaling up or scaling out cell therapy manufacturing.
-
![DeciBio_LI_promo]( "On The Ground At BPI: Industry Reflections With Carl Schoellhammer, Ph.D.")
On The Ground At BPI: Industry Reflections With Carl Schoellhammer, Ph.D.9/25/2025DeciBio partner Carl Schoellhammer, Ph.D., speaks on the record with Bioprocess Online's chief editor Tyler Menichiello at the 2025 BioProcess International conference in Boston.
-
![Business Team Climbing, Leadership, Growth, Unity-GettyImages-2114194800]( "How CGT Leaders Are Reducing Failures, Scaling Processes, And Overcoming Regulatory Friction")
How CGT Leaders Are Reducing Failures, Scaling Processes, And Overcoming Regulatory Friction6/30/2025Industry leaders share their philosophy on reducing product failure, embracing AI, and building dynamic teams to stay ahead of the curve to bring curative CGT therapies to patients.
-
![Human Cell-GettyImages-1533148452]( "2025 Cell Therapy Outlook From BPI West")
2025 Cell Therapy Outlook From BPI West3/31/2025Bioprocess Online and Cell & Gene spoke with Takeda’s Amy Shaw at BPI West to discuss the industry and her key takeaways from the conference.
-
![San Diego Convention Center]( "Impressions And Takeaways From BPI West 2025")
Impressions And Takeaways From BPI West 20253/27/2025Editor Tyler Menichiello reviews the most compelling topics and sessions from this year's BioProcess International U.S. West.
-
![GettyImages-2189938556-cancer-cell]( "Arcellx On Designing A Dynamic CAR-T")
Arcellx On Designing A Dynamic CAR-T3/13/2025Arcellx's CMO and CTO talk about the company's platform technology, its partnership with Kite, and preparing its lead asset, anito-cel, for commercial launch.
-
![Winning strategy efficiency innovation-+GettyImages-1359225856]( "Easing Autologous Cell Collection, Automating Manufacturing")
Easing Autologous Cell Collection, Automating Manufacturing1/22/2025To circumvent the challenges of leukapheresis, CellProthera developed a novel method for collecting therapeutic stem cells from whole blood. CSO Ibon Garitaonandia, Ph.D., discusses the company's mission to streamline manufacturing.
-
![biochemical laboratory, research institute-GettyImages-1485990190]( "Industry Leaders On Analytical Method Development")
Industry Leaders On Analytical Method Development1/7/2025Experts from Bristol Myers Squibb and Moffitt Cancer Center discuss best practices for analytical method development, as well as how to manage the successful transfer of these methods.
-
![Short_6]( "Optimism For Biopharma In 2025")
Optimism For Biopharma In 202512/27/2024In this closing segment from the executive roundtable discussion, our panelists express their confidence in the industry's mission and maintain a positive outlook for the years ahead.
-
![Short_5]( "How Biotechs Can Navigate Market Uncertainty In 2025")
How Biotechs Can Navigate Market Uncertainty In 202512/27/2024In this segment of the executive roundtable discussion, our panelists weigh in on how to prepare for what may be a challenging financial climate in 2025.
